{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T15:56:27Z","timestamp":1781538987506,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22165006"],"award-info":[{"award-number":["22165006"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Natural Science Foundation of Guangxi Province","doi-asserted-by":"publisher","award":["2022GXNSFDA035085"],"award-info":[{"award-number":["2022GXNSFDA035085"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s11095-026-04114-3","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T18:17:17Z","timestamp":1778523437000},"page":"1501-1516","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preparation of SP94-Modified Calcium Phosphate Lipid Nanoparticles Loaded with Bcl-2 siRNA and Doxorubicin and Their Targeted Therapeutic Effect on Hepatocellular Carcinoma"],"prefix":"10.1007","volume":"43","author":[{"given":"Kailun","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyi","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqi","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"4114_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"15","key":"4114_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26157137","volume":"26","author":"TW Chen","year":"2025","unstructured":"Chen TW, Fan HL, Liu ST, Huang SM. Chemosensitizer effects of Cisplatin and 5-Fluorouracil-treated hepatocellular carcinomas by Lidocaine. Int J Mol Sci. 2025;26(15):7137.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4114_CR3","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3350\/cmh.2022.0391","volume":"29","author":"H Iwamoto","year":"2023","unstructured":"Iwamoto H, Shimose S, Shirono T, Niizeki T, Kawaguchi T. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity. Clin Mol Hepatol. 2023;29(3):593\u2013604.","journal-title":"Clin Mol Hepatol"},{"issue":"5","key":"4114_CR4","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s40259-022-00549-3","volume":"36","author":"M Friedrich","year":"2022","unstructured":"Friedrich M, Aigner A. Therapeutic siRNA: state-of-the-art and future perspectives. BioDrugs. 2022;36(5):549\u201371.","journal-title":"BioDrugs"},{"issue":"7","key":"4114_CR5","doi-asserted-by":"publisher","first-page":"792","DOI":"10.2174\/0115665240303370240530120450","volume":"25","author":"M Shahverdi","year":"2025","unstructured":"Shahverdi M, Alamdari-Palangi V, Alipour S, Ghaffari Jolfayi A, Masoumi J, Aghebati-Maleki L, et al. Recent Advances in Immune Regulation by Targeting Dendritic Cells using Small Interfering RNAs. Curr Mol Med. 2025;25(7):792\u2013809.","journal-title":"Curr Mol Med"},{"key":"4114_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114432","volume":"189","author":"MM Zhang","year":"2021","unstructured":"Zhang MM, Bahal R, Rasmussen TP, Manautou JE, Zhong XB. The growth of siRNA-based therapeutics: updated clinical studies. Biochem Pharmacol. 2021;189:114432.","journal-title":"Biochem Pharmacol"},{"key":"4114_CR7","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/jcph.1553","volume":"60","author":"X Zhang","year":"2020","unstructured":"Zhang X, Goel V, Robbie GJ. Pharmacokinetics of Patisiran, the first approved RNA interference therapy in patients with hereditary Transthyretin-mediated amyloidosis. J Clin Pharmacol. 2020;60:573\u201385.","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"4114_CR8","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ymthe.2024.01.005","volume":"32","author":"M Moazzam","year":"2024","unstructured":"Moazzam M, Zhang M, Hussain A, Yu X, Huang J, Huang Y. The landscape of nanoparticle-based siRNA delivery and therapeutic development. Mol Ther. 2024;32(2):284\u2013312.","journal-title":"Mol Ther"},{"issue":"1","key":"4114_CR9","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2025.13537","volume":"32","author":"AA Palabiyik","year":"2025","unstructured":"Palabiyik AA. The role of Bcl-2 in controlling the transition between autophagy and apoptosis (review). Mol Med Rep. 2025;32(1):172.","journal-title":"Mol Med Rep"},{"issue":"3","key":"4114_CR10","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.bbrc.2016.10.100","volume":"482","author":"RL Schenk","year":"2017","unstructured":"Schenk RL, Strasser A, Dewson G. BCL-2: long and winding path from discovery to therapeu-tic target. Biochem Biophys Res Commun. 2017;482(3):459\u201369.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"4114_CR11","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/PPO.0000000000000408","volume":"25","author":"CE Ryan","year":"2019","unstructured":"Ryan CE, Davids MS. BCL-2 inhibitors, present and future. Cancer J. 2019;25(6):401\u20139.","journal-title":"Cancer J"},{"key":"4114_CR12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1440-1746.2010.06582.x","volume":"26","author":"JM Schattenberg","year":"2011","unstructured":"Schattenberg JM, Schuchmann M, Galle PR. Cell death and hepatocarcinogenesis: dysregulation of apoptosis signaling pathways. J Gastroenterol Hepatol. 2011;26:213\u20139.","journal-title":"J Gastroenterol Hepatol"},{"key":"4114_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.120241","volume":"352","author":"M Zhong","year":"2025","unstructured":"Zhong M, Li Y, Wang H, Fan N, Chu X, Liu L, et al. Integrated network pharmacology and experimental validation reveal EGFR\/p53\/Bcl-2-mediated antihepatocellular carcinoma effects of Zedoary Turmeric Oil. J Ethnopharmacol. 2025;352:120241.","journal-title":"J Ethnopharmacol"},{"key":"4114_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/4972523","volume":"2024","author":"AJ de Melo Silva","year":"2024","unstructured":"de Melo Silva AJ, de Melo Gama JE, de Oliveira SA. The role of Bcl-2 family proteins and Sorafenib resistance in hepatocellular carcinoma. Int J Cell Biol. 2024;2024:4972523.","journal-title":"Int J Cell Biol"},{"issue":"23","key":"4114_CR15","doi-asserted-by":"publisher","first-page":"13091","DOI":"10.3390\/ijms252313091","volume":"25","author":"D Bollino","year":"2024","unstructured":"Bollino D, Ma X, Tighe KM, Casildo A, Richard K, Passaniti A, et al. Calaspargase-Pegol-Mknl Combined with BCL-2 and MCL-1 Inhibition for Acute Myeloid Leukemia. Int J Mol Sci. 2024;25(23):13091.","journal-title":"Int J Mol Sci"},{"key":"4114_CR16","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1158\/0008-5472.CAN-05-2097","volume":"66","author":"F Manero","year":"2006","unstructured":"Manero F, Gautier F, Gallenne T, Cauquil N, Gr\u00e9e D, Cartron P, et al. The small o rganic compound HA14-1 prevents Bcl-2 interaction with Bax to sensitize malignant glioma cells to induction of cell death. Can Res. 2006;66:2757\u201364.","journal-title":"Can Res"},{"issue":"1","key":"4114_CR17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3390\/pharmaceutics14010097","volume":"14","author":"M Gagliardi","year":"2022","unstructured":"Gagliardi M, Ashizawa AT. Making sense of antisense oligonucleotide therapeutics targeting Bcl-2. Pharmaceutics. 2022;14(1):97.","journal-title":"Pharmaceutics"},{"key":"4114_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.122074","volume":"625","author":"C Yan","year":"2022","unstructured":"Yan C, Gu J, Zhang Y, Ma K, Lee RJ. Efficient delivery of the Bcl-2 antisense oligonucleotide G3139 via nucleus-targeted aCD33-NKSN nanoparticles. Int J Pharm. 2022;625:122074.","journal-title":"Int J Pharm"},{"key":"4114_CR19","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1016\/j.biomaterials.2010.11.061","volume":"32","author":"N Cao","year":"2011","unstructured":"Cao N, Cheng D, Zou S, Ai H, Gao J, Shuai X. The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells. Biomaterials. 2011;32:2222\u201332.","journal-title":"Biomaterials"},{"key":"4114_CR20","volume":"24","author":"Y Wu","year":"2025","unstructured":"Wu Y, Li T, Lortie F, Bernard J, Binder WH, Chen S, et al. Supramolecular Micelleplex Co- Delivers Bcl-2 siRNA and Paclitaxel for Synergistic Chemo-Gene Cancer Therapy. Small Methods. 2025;24:e00760.","journal-title":"Small Methods"},{"key":"4114_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2025.115365","volume":"259","author":"Y Sun","year":"2025","unstructured":"Sun Y, Guo R, Xu H, Jing Z, Du Q, Chen F, et al. Polydopamine-modified cyclodextrin metal-organic framework for efficient BCL-2 siRNA delivery in lung cancer therapy. Colloids Surf B Biointerfaces. 2025;259:115365.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"5","key":"4114_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26052234","volume":"26","author":"YH Choi","year":"2025","unstructured":"Choi YH, Kim HY, Park JO, Choi E. Enhanced anti-tumor effects of natural killer cell-derived exosomes through doxorubicin delivery to hepatocellular carcinoma cells: cytotoxicity and apoptosis study. Int J Mol Sci. 2025;26(5):2234.","journal-title":"Int J Mol Sci"},{"key":"4114_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124424","volume":"661","author":"C Cao","year":"2024","unstructured":"Cao C, Li Y, Shi F, Jiang S, Li Y, Yang L, et al. Nano co-delivery of doxorubicin and plumbagin achieves synergistic chemotherapy of hepatocellular carcinoma. Int J Pharm. 2024;661:124424.","journal-title":"Int J Pharm"},{"issue":"9","key":"4114_CR24","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.1007\/s00204-025-04112-1","volume":"99","author":"S Sritharan","year":"2025","unstructured":"Sritharan S, Sivalingam N. A recent decade update on combating doxorubicin-induced toxicities. Arch Toxicol. 2025;99(9):3565\u201378.","journal-title":"Arch Toxicol"},{"issue":"3","key":"4114_CR25","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1039\/D1TB02540F","volume":"10","author":"J Liu","year":"2022","unstructured":"Liu J, Hu X, Jin S, Liang XJ, Ma X. Enhanced anti-tumor activity of a drug through pH-triggered release and dual targeting by calcium phosphate-covered mesoporous silica vehicles. J Mater Chem B. 2022;10(3):384\u201395.","journal-title":"J Mater Chem B"},{"issue":"5","key":"4114_CR26","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1080\/10837450.2022.2090958","volume":"27","author":"Y Shen","year":"2022","unstructured":"Shen Y, Ma H. Oridonin-loaded lipid-coated calcium phosphate nanoparticles: preparation, characterization, and application in A549 lung cancer. Pharm Dev Technol. 2022;27(5):598\u2013605.","journal-title":"Pharm Dev Technol"},{"issue":"7","key":"4114_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202410545","volume":"12","author":"P Liu","year":"2025","unstructured":"Liu P, Guo J, Xie Z, Pan Y, Wei B, Peng Y, et al. Co-Delivery of aPD-L1 and CD73 Inhibitor Using Calcium Phosphate Nanoparticles for Enhanced Melanoma Immunotherapy with Reduced Toxicity. Adv Sci (Weinh). 2025;12(7):e2410545.","journal-title":"Adv Sci (Weinh)"},{"key":"4114_CR28","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S0022-2836(65)80093-6","volume":"13","author":"AD Bangham","year":"1965","unstructured":"Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol. 1965;13:238\u201352.","journal-title":"J Mol Biol"},{"issue":"5","key":"4114_CR29","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1042\/bj1240058p","volume":"124","author":"G Gregoriadis","year":"1971","unstructured":"Gregoriadis G, Ryman BE. Liposomes as carriers of enzymes or drugs: a new approach to the treatment of storage diseases. The Bi-ochemical journal. 1971;124:58.","journal-title":"The Bi-ochemical journal"},{"issue":"3","key":"4114_CR30","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.jconrel.2009.11.008","volume":"142","author":"J Li","year":"2010","unstructured":"Li J, Chen YC, Tseng YC, Mozumdar S, Huang L. Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery. J Control Release. 2010;142(3):416\u201321.","journal-title":"J Control Release"},{"issue":"7","key":"4114_CR31","doi-asserted-by":"publisher","first-page":"918","DOI":"10.7150\/thno.14689","volume":"6","author":"AB Satterlee","year":"2016","unstructured":"Satterlee AB, Huang L. Current and future theranostic applications of the lipid-calcium-phosphate nanoparticle platform. Theranostics. 2016;6(7):918\u201329.","journal-title":"Theranostics"},{"issue":"1","key":"4114_CR32","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1158\/0008-5472.CAN-21-2269","volume":"82","author":"H Sendi","year":"2022","unstructured":"Sendi H, Yazdimamaghani M, Hu M, Sultanpuram N, Wang J, Moody AS, et al. Nanoparticle delivery of miR-122 inhibits colorectal cancer liver metastasis. Cancer Res. 2022;82(1):105\u201313.","journal-title":"Cancer Res"},{"key":"4114_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/srep33511","volume":"6","author":"Y Li","year":"2016","unstructured":"Li Y, Hu Y, Xiao J, Liu G, Li X, Zhao Y, et al. Investigation of SP94 peptide as a specific probe for hepatocellular carcinoma imaging and therapy. Sci Rep. 2016;6:33511.","journal-title":"Sci Rep"},{"key":"4114_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2020.111399","volume":"197","author":"J Zhang","year":"2021","unstructured":"Zhang J, Wang X, Cheng L, Yuan J, Zhong Z. SP94 peptide mediating highly specific and efficacious delivery of polymersomal doxorubicin hydrochloride to hepatocellular carcinoma in vivo. Colloids Surf B Biointerfaces. 2021;197:111399.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"4","key":"4114_CR35","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1021\/acs.nanolett.0c03756","volume":"21","author":"M Li","year":"2021","unstructured":"Li M, Jiang S, Simon J, Pa\u00dflick D, Frey ML, Wagner M, et al. Brush conformation of Polyethylene Glycol determines the stealth effect of nanocarriers in the low protein adsorption regime. Nano Lett. 2021;21(4):1591\u20138.","journal-title":"Nano Lett"},{"issue":"8","key":"4114_CR36","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.3390\/cimb44080256","volume":"44","author":"D Mofed","year":"2022","unstructured":"Mofed D, Wahba MA, Salem TZ. Genetically engineered Hepatitis C virus-like particles (HCV-LPs) tagged with SP94 peptide to acquire selectivity to liver cancer cells via Grp78. Curr Issues Mol Biol. 2022;44(8):3746\u201356.","journal-title":"Curr Issues Mol Biol"},{"issue":"14","key":"4114_CR37","doi-asserted-by":"publisher","first-page":"4964","DOI":"10.1039\/D0AN00108B","volume":"145","author":"X Wang","year":"2020","unstructured":"Wang X, Peng C, He K, Ji K, Tan X, Han G, et al. Intracellular delivery of liposome-encapsulated Finland trityl radicals for EPR oximetry. Analyst. 2020;145(14):4964\u201371.","journal-title":"Analyst"},{"issue":"8","key":"4114_CR38","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1039\/C9RA07894K","volume":"10","author":"Z Cai","year":"2020","unstructured":"Cai Z, Chen Y, Zhang Y, He Z, Wu X, Jiang LP. pH-sensitive CAP\/SiO(2) composite for efficient co-delivery of doxorubicin and siRNA to overcome multiple drug resistance. RSC Adv. 2020;10(8):4251\u20137.","journal-title":"RSC Adv"},{"key":"4114_CR39","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.2147\/IJN.S191341","volume":"14","author":"X Pang","year":"2019","unstructured":"Pang X, Wang T, Jiang D, Mu W, Zhang B, Zhang N. Functionalized docetaxel-loaded lipid-based-nanosuspensions to enhance antitumor efficacy in vivo. Int J Nanomedicine. 2019;14:2543\u201355.","journal-title":"Int J Nanomedicine"},{"issue":"22","key":"4114_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/polym17222979","volume":"17","author":"P Folda","year":"2025","unstructured":"Folda P, Weidinger E, Seidl J, Yazdi M, P\u00f6hmerer J, Grau M, et al. PEGylation enhances colloidal stability and promotes ligand-mediated targeting of LAF-Xenopeptide mRNA complexes. Polymers. 2025;17(22):2979.","journal-title":"Polymers"},{"issue":"8","key":"4114_CR41","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s12032-025-02919-7","volume":"42","author":"J Wang","year":"2025","unstructured":"Wang J, Yue Z, Bu J, Quan S, Guo R, Wang M, et al. Duloxetine inhibits breast cancer progression by suppressing AKT signaling and inducing Bax\/Bcl-2-mediated apoptosis. Med Oncol. 2025;42(8):364.","journal-title":"Med Oncol"},{"key":"4114_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2023.213683","volume":"155","author":"F Raza","year":"2023","unstructured":"Raza F, Zheng M, Zhong H, Su J, He B, Yuan W, et al. Engineered tumor microvesicles modified by SP94 peptide for arsenic trioxide targeting drug delivery in liver cancer therapy. Biomater Adv. 2023;155:213683.","journal-title":"Biomater Adv"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04114-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-026-04114-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04114-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T15:30:31Z","timestamp":1781537431000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-026-04114-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["4114"],"URL":"https:\/\/doi.org\/10.1007\/s11095-026-04114-3","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"16 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No conflict of interest declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}